EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nanozymes for Non‐Neoplastic Diseases: Catalytic Therapy Redefined

Ling Mei, Xikai Wang, Zhuang Hu, Jierui Yan, Xiaobo Wang, Haoran Wang, Ya Hou, Pengfei Zhang, Qihang Ding

Aggregate · 2025-11 · 6 (11)

DOI: 10.1002/agt2.70150 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aggregate, online erschienen am 15.09.2025. Verfasst von Ling Mei und 8 weiteren Autor:innen. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 237 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Scholarship Council, Shenzhen Science and Technology Innovation Program.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non‐neoplastic diseases, such as cardiovascular, neurodegenerative, metabolic, and inflammatory disorders, are major global health challenges with complex pathophysiologies that demand precise and innovative therapeutic strategies. Nanozymes, artificial nanomaterials with enzyme‐like catalytic functions, have recently emerged as promising candidates for such interventions. Distinguished by their programmable structures, tunable activities, and excellent biocompatibility, nanozymes can mimic multiple natural enzymes (e.g., superoxide dismutase, catalase, and peroxidase) to modulate oxidative stress and inflammation. Beyond catalytic activity, their functional integration enables immune regulation and metabolic reprogramming, facilitating multilevel (molecular to tissue) microenvironmental remodeling. This review highlights recent progress in nanozyme development for non‐neoplastic disease therapy, emphasizing structure–function relationships, activity regulation in pathological conditions, and mechanistic roles in disrupting the oxidative stress–inflammation–immune dysregulation loop. We further summarize representative applications across cardiovascular diseases, neurodegenerative conditions, metabolic disorders, and inflammatory pathologies, focusing on advances in targeted delivery, responsive release, and multimodal theranostics. These insights collectively underline the transformative potential of nanozymes in next‐generation precision medicine.

Förderung

  • China Scholarship Council
  • Shenzhen Science and Technology Innovation Program

Zitieren

APA

Mei, L., Wang, X., Hu, Z., Yan, J., Wang, X., Wang, H., Hou, Y., Zhang, P., & Ding, Q. (2025). Nanozymes for Non‐Neoplastic Diseases: Catalytic Therapy Redefined. Aggregate, 6(11). https://doi.org/10.1002/agt2.70150

Vancouver

Mei L, Wang X, Hu Z, Yan J, Wang X, Wang H, et al. Nanozymes for Non‐Neoplastic Diseases: Catalytic Therapy Redefined. Aggregate. 2025;6(11). doi:10.1002/agt2.70150

BibTeX
@article{Mei2025,
  author = {Mei, Ling and Wang, Xikai and Hu, Zhuang and Yan, Jierui and Wang, Xiaobo and Wang, Haoran and Hou, Ya and Zhang, Pengfei and Ding, Qihang},
  title = {Nanozymes for Non‐Neoplastic Diseases: Catalytic Therapy Redefined},
  journal = {Aggregate},
  year = {2025},
  volume = {6},
  number = {11},
  doi = {10.1002/agt2.70150}
}
Kostenlos starten →